Peter Garred

23.0k total citations · 1 hit paper
416 papers, 17.2k citations indexed

About

Peter Garred is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Peter Garred has authored 416 papers receiving a total of 17.2k indexed citations (citations by other indexed papers that have themselves been cited), including 287 papers in Immunology, 81 papers in Hematology and 60 papers in Molecular Biology. Recurrent topics in Peter Garred's work include Complement system in diseases (212 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (41 papers) and Monoclonal and Polyclonal Antibodies Research (41 papers). Peter Garred is often cited by papers focused on Complement system in diseases (212 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (41 papers) and Monoclonal and Polyclonal Antibodies Research (41 papers). Peter Garred collaborates with scholars based in Denmark, Norway and United States. Peter Garred's co-authors include Hans O. Madsen, Arne Svejgaard, Lea Munthe‐Fog, Tina Hummelshøj, Claus Koch, Tom Eirik Mollnes, Mikkel‐Ole Skjoedt, Ying Jie, Steffen Thiel and Christian Honoré and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Peter Garred

400 papers receiving 16.9k citations

Hit Papers

Interplay between promote... 1995 2026 2005 2015 1995 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Peter Garred 11.2k 2.5k 2.5k 2.4k 2.0k 416 17.2k
Taco W. Kuijpers 8.9k 0.8× 2.6k 1.0× 4.0k 1.6× 2.6k 1.1× 2.3k 1.1× 478 17.8k
Seppo Meri 9.0k 0.8× 2.6k 1.0× 3.0k 1.2× 2.5k 1.1× 2.0k 1.0× 389 17.4k
Anna M. Blom 6.9k 0.6× 2.0k 0.8× 2.9k 1.2× 1.9k 0.8× 1.5k 0.8× 357 13.8k
Enrico Maggi 15.6k 1.4× 2.6k 1.0× 3.6k 1.5× 1.0k 0.4× 1.2k 0.6× 367 27.2k
David Klatzmann 12.0k 1.1× 3.8k 1.5× 4.2k 1.7× 1.5k 0.6× 2.7k 1.3× 358 22.3k
Thomas J. Schall 15.7k 1.4× 2.9k 1.2× 4.3k 1.8× 1.1k 0.4× 1.6k 0.8× 185 25.8k
Raif S. Geha 19.4k 1.7× 2.4k 1.0× 5.3k 2.1× 2.4k 1.0× 1.4k 0.7× 501 31.8k
Fabio Facchetti 10.5k 0.9× 2.9k 1.2× 2.5k 1.0× 1.3k 0.5× 971 0.5× 339 20.2k
Sergio Romagnani 20.6k 1.8× 3.7k 1.5× 4.7k 1.9× 1.3k 0.5× 1.8k 0.9× 350 36.0k
George Janossy 9.2k 0.8× 2.8k 1.1× 3.3k 1.3× 3.4k 1.4× 2.0k 1.0× 298 18.9k

Countries citing papers authored by Peter Garred

Since Specialization
Citations

This map shows the geographic impact of Peter Garred's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Garred with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Garred more than expected).

Fields of papers citing papers by Peter Garred

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Garred. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Garred. The network helps show where Peter Garred may publish in the future.

Co-authorship network of co-authors of Peter Garred

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Garred. A scholar is included among the top collaborators of Peter Garred based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Garred. Peter Garred is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Skjoedt, Karsten, et al.. (2025). Isoform-specific detection and quantification of complement C4A via novel mAbs. Immunobiology. 230(4). 152940–152940.
4.
Pérez‐Alós, Laura, et al.. (2025). Inhibition of Alternative and Terminal Complement Pathway Components Modulate the Immune Response Against Bacteria and Fungi in Whole Blood. Scandinavian Journal of Immunology. 101(5). e70030–e70030. 1 indexed citations
5.
Snir, Omri, Kristian Hindberg, Sigrid K. Brækkan, et al.. (2025). Elevated Plasma MBL Levels Are Associated With Risk of Future Venous Thromboembolism: The HUNT Study. Arteriosclerosis Thrombosis and Vascular Biology. 45(7). e324–e335.
6.
Bayarri‐Olmos, Rafael, Anne Rosbjerg, Charlotte Helgstrand, et al.. (2024). Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responses. Frontiers in Immunology. 15. 1412873–1412873. 1 indexed citations
7.
Ammitzbøll, Christian Gytz, Marianne Kragh Thomsen, Lars Erik Bartels, et al.. (2024). COVID‐19 Vaccination Before Initiating Rituximab Treatment Induces Strong Serological Response in Autoimmune Rheumatic Disease, Reducing Post‐Pandemic Concerns About the Impact of Rituximab. ACR Open Rheumatology. 6(8). 519–528. 4 indexed citations
8.
Rambach, Günter, Christian X. Weichenberger, Peter Garred, et al.. (2022). Influence of Glucose on Candida albicans and the Relevance of the Complement FH-Binding Molecule Hgt1 in a Murine Model of Candidiasis. Antibiotics. 11(2). 257–257. 8 indexed citations
9.
Hansen, Cecilie Bo, Håkon Sandholdt, Laura Pérez‐Alós, et al.. (2022). Prediction of Respiratory Failure and Mortality in COVID-19 Patients Using Long Pentraxin PTX3. Journal of Innate Immunity. 14(5). 493–501. 23 indexed citations
10.
Msemo, Omari Abdul, Laura Pérez‐Alós, Daniel T. R. Minja, et al.. (2022). High anti-SARS-CoV-2 seroprevalence among unvaccinated mother–child pairs from a rural setting in north-eastern Tanzania during the second wave of COVID-19. IJID Regions. 6. 48–57.
11.
Boer, Eline de, Marina Sokolova, Viktoriia Chaban, et al.. (2022). Synthetic Oligodeoxynucleotide CpG Motifs Activate Human Complement through Their Backbone Structure and Induce Complement-Dependent Cytokine Release. The Journal of Immunology. 209(9). 1760–1767. 5 indexed citations
12.
Fogh, Kamille, Cecilie Bo Hansen, Pernille Brok Nielsen, et al.. (2021). Anti-SARS-CoV-2 Seropositivity Among Medical Students in Copenhagen. Open Forum Infectious Diseases. 8(8). 7 indexed citations
13.
Garred, Peter, Andrea J. Tenner, & Tom Eirik Mollnes. (2021). Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics. Pharmacological Reviews. 73(2). 792–827. 134 indexed citations
14.
Hedetoft, Morten, Martin Bruun Madsen, Cecilie Bo Hansen, Ole Hyldegaard, & Peter Garred. (2021). Increase in the Complement Activation Product C4d and the Terminal Complement Complex sC5b-9 Is Associated with Disease Severity and a Fatal Outcome in Necrotizing Soft-Tissue Infection. Journal of Innate Immunity. 14(4). 355–365.
15.
Chatterjee, Sneha, Rafael Bayarri‐Olmos, Heribert Talasz, et al.. (2020). Shiga Toxin 2a Binds to Complement Components C3b and C5 and Upregulates Their Gene Expression in Human Cell Lines. Toxins. 13(1). 8–8. 2 indexed citations
16.
Jürgensen, Henrik J., Eric Santoni‐Rugiu, Daniel H. Madsen, et al.. (2018). Immune regulation by fibroblasts in tissue injury depends on uPARAP-mediated uptake of collectins. The Journal of Cell Biology. 218(1). 333–349. 13 indexed citations
17.
Banda, Nirmal K., Robert I. Scheinman, Rasmus Pihl, et al.. (2018). Targeting of Liver Mannan-Binding Lectin–Associated Serine Protease-3 with RNA Interference Ameliorates Disease in a Mouse Model of Rheumatoid Arthritis. ImmunoHorizons. 2(8). 274–295. 15 indexed citations
18.
Bakke, Siril S., Marie Aune, Nathalie Niyonzima, et al.. (2017). Cyclodextrin Reduces Cholesterol Crystal–Induced Inflammation by Modulating Complement Activation. The Journal of Immunology. 199(8). 2910–2920. 40 indexed citations
19.
Pilely, Katrine, Anne Rosbjerg, Ninette Genster, et al.. (2016). Cholesterol Crystals Activate the Lectin Complement Pathway via Ficolin-2 and Mannose-Binding Lectin: Implications for the Progression of Atherosclerosis. The Journal of Immunology. 196(12). 5064–5074. 34 indexed citations
20.
Harboe, M, et al.. (2006). Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions. Clinical & Experimental Immunology. 144(3). 512–520. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026